Khanh-Thien Le
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Khanh-Thien Le has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Hieu Tran-Van
Laboratory of Biosensors, Faculty of Biology and Biotechnology, University of Science, Ho Chi Minh City, Vietnam
2 shared publications - Thuoc Linh Tran
Faculty of Biology and Biotechnology, University of Science, Ho Chi Minh City, Vietnam
2 shared publications Cong-Thuan Nguyen
1 shared publicationLe-Giang Thi Nguyen
1 shared publication- Le-Giang Thi Nguyen
Faculty of Biology and Biotechnology, University of Science, Ho Chi Minh City, Vietnam
1 shared publication Phuong-Cac Hoang-Thai
Institute of Drug Quality Control, Ho Chi Minh City, Vietnam
1 shared publication
Latest Publications
- 1 November 2020
- Published by Taylor & Francis in Growth Factors
- Vol. 38 (5-6) , 282-290
Third-degree burn mouse treatment using recombinant human fibroblast growth factor 2
Fibroblast growth factor 2 (FGF-2) is a multifunctional protein that has major roles in wound healing, tissue repair, and regeneration. This therapeutic protein is widely used for burn treatment because it can stimulate cell proliferation and differentiation, angiogenesis, and extracellular matrix remodeling. In this study, we developed a simple method using a controlled heated brass rod to create a homogenous third-degree burn murine model and evaluated the treatment using recombinant human FGF-2 (rhFGF-2). The results indicated that the wound area was 0.83 ± 0.05 cm2 and wound depth was 573.42 ± 147.82 μm. Mice treated with rhFGF-2 showed higher rates of wound closure, granulation tissue formation, angiogenesis, and re-epithelialization than that of phosphate-buffered saline (PBS)-treated group. In conclusion, our lab-made rhFGF-2 could be a potentially therapeutic protein for burn treatment as well as a bioequivalent drug for other commercial applications using FGF-2.
- 1 November 2020
- Published by Taylor & Francis in Growth Factors
- Vol. 38 (5-6) , 282-290
Third-degree burn mouse treatment using recombinant human fibroblast growth factor 2
Fibroblast growth factor 2 (FGF-2) is a multifunctional protein that has major roles in wound healing, tissue repair, and regeneration. This therapeutic protein is widely used for burn treatment because it can stimulate cell proliferation and differentiation, angiogenesis, and extracellular matrix remodeling. In this study, we developed a simple method using a controlled heated brass rod to create a homogenous third-degree burn murine model and evaluated the treatment using recombinant human FGF-2 (rhFGF-2). The results indicated that the wound area was 0.83 ± 0.05 cm2 and wound depth was 573.42 ± 147.82 μm. Mice treated with rhFGF-2 showed higher rates of wound closure, granulation tissue formation, angiogenesis, and re-epithelialization than that of phosphate-buffered saline (PBS)-treated group. In conclusion, our lab-made rhFGF-2 could be a potentially therapeutic protein for burn treatment as well as a bioequivalent drug for other commercial applications using FGF-2.